financetom
Business
financetom
/
Business
/
Qualcomm strengthens AI portfolio with $2.4 billion Alphawave deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Qualcomm strengthens AI portfolio with $2.4 billion Alphawave deal
Jun 9, 2025 12:55 AM

*

Cash offer of 183 pence per Alphawave share

*

Offer at a 96% premium to AWE's shares at March 31 close

*

Qualcomm ( QCOM ) also tabled alternative share offers

(Adds background in paragraphs 3-5, details throughout)

June 9 (Reuters) - U.S. chipmaker Qualcomm ( QCOM ) on

Monday agreed to acquire British semiconductor company Alphawave

for about $2.4 billion as part of efforts to strengthen

its artificial intelligence technology.

Alphawave shareholders will receive 183 pence per share, a

nearly 96% premium to the price immediately before Qualcomm ( QCOM )

disclosed its interest in the company. The shares jumped 22% in

early London trade to just below the offer price.

U.S.-based firms have been snapping up British assets,

taking advantage of a market that is plagued by comparatively

weaker valuations and stunted growth.

Alphawave, which designs and licenses semiconductor

technology for data centers, networking and storage, had

garnered takeover interest from Qualcomm ( QCOM ) and SoftBank-owned chip

tech provider Arm in early April for its 'serdes'

technology.

The technology underpins the speed at which data is

processed by chips - crucial for AI development - and serves as

the foundation for Broadcom's ( AVGO ) and Marvell Technology's ( MRVL )

multibillion-dollar bespoke chip businesses.

Arm walked away after initial discussions with Alphawave,

Reuters exclusively reported in April citing sources.

Qualcomm ( QCOM ) also tabled two alternative all-share offers to

Alphawave's shareholders, after receiving multiple extensions

from the UK's takeover panel to table a firm offer.

The British company said it considers the terms of the cash

offer to be fair and reasonable and intends to unanimously

recommend it to its shareholders.

Alphawave also completed the disposal of its stake in

WiseWave, its joint venture with Chinese investment firm Wise

Road Capital, to existing state shareholders on Monday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ferrari Shares Race Higher On Strong Q2 Results
Ferrari Shares Race Higher On Strong Q2 Results
Aug 1, 2024
Ferrari N.V. ( RACE ) shares are trading higher Thursday after the company posted better-than-expected second-quarter financial results.  The Details: Ferrari ( RACE ) reported earnings of $2.47 per share on quarterly revenue of $1.84 billion, beating estimates on both the top and bottom line.  The company said second-quarter shipments increased 2.7% year-over-year to 3,484 units. The Ferrari Purosangue, the...
XPeng July Deliveries Rise 1%
XPeng July Deliveries Rise 1%
Aug 1, 2024
11:27 AM EDT, 08/01/2024 (MT Newswires) -- XPeng ( XPEV ) said Thursday it delivered 11,145 vehicles in July, up 1% year-over-year and 4% from June. The company said it delivered 63,173 vehicles in the first seven months of the year, up 20% year-over-year. XPeng ( XPEV ) shares were down 3.3% in recent trading. Price: 7.80, Change: -0.27, Percent...
InMode Shares Fall After Q2 Miss
InMode Shares Fall After Q2 Miss
Aug 1, 2024
11:26 AM EDT, 08/01/2024 (MT Newswires) -- InMode ( INMD ) shares fell more than 7% in recent Thursday trading after the company posted lower Q2 results that also missed analysts' expectations. The company reported Q2 non-GAAP earnings of $0.34 per diluted share, down from $0.72 a year earlier. Analysts polled by Capital IQ expected $0.38. Revenue for the quarter...
Biogen Q2 Earnings: Beats Consensus, Lifts 2024 Profit Forecast As New Drug Launches Expected To Offset Decline In Multiple Sclerosis Med Sales
Biogen Q2 Earnings: Beats Consensus, Lifts 2024 Profit Forecast As New Drug Launches Expected To Offset Decline In Multiple Sclerosis Med Sales
Aug 1, 2024
On Thursday, Biogen Inc ( BIIB ) reported second-quarter adjusted EPS of $5.28, up 31%, beating the consensus of $4.03. The company reported sales of $2.47 billion, almost flat year over year and up 1% on constant currency, beating the consensus of $2.38 billion. Multiple sclerosis revenue of $1.15 billion decreased by 5% (down 5% on constant currency). Multiple sclerosis drug Tysabri...
Copyright 2023-2026 - www.financetom.com All Rights Reserved